Tao Xie1, Un Jung Kang, Peter Warnke. 1. Department of Neurology, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 2030, Chicago, IL 60637, USA. txie@bsd.uchicago.edu
Abstract
BACKGROUND: Patients with Parkinson's disease (PD) may develop freezing of gait (FOG) with chronic deep brain stimulation (DBS) of the subthalamic nucleus (STN) at the commonly used frequency of 130 Hz and FOG can be ameliorated by 60 Hz stimulation in some patients. It is not clear whether the development of FOG is due to the disease progression or the chronic stimulation at this 130 Hz frequency. AIMS: To investigate the effect of stimulation frequency on immediate FOG in newly activated STN DBS patient with PD and determine if stimulation frequency alone could affect the FOG. METHODS: Two cases of PD who developed FOG immediately upon activation of the newly placed STN DBS were studied for the effect of stimulation frequency on FOG in both `off' and `on' medication status. RESULTS: Both patients developed severe FOG with the commonly used 130 Hz stimulation. Switching the frequency to 60 Hz immediately alleviated the FOG, without change in contacts, voltages and pulse widths. This frequency effect on FOG was present in both `off' and `on' statuses and remained effective during the 10-month follow-up period. CONCLUSION: These two cases demonstrate that lower frequency stimulation of 60 Hz could improve FOG, while the commonly used 130 Hz stimulation could cause FOG or make it worse. In addition, the beneficial effect of low frequency DBS was additive to dopaminergic medication effect and included other axial symptoms.
BACKGROUND:Patients with Parkinson's disease (PD) may develop freezing of gait (FOG) with chronic deep brain stimulation (DBS) of the subthalamic nucleus (STN) at the commonly used frequency of 130 Hz and FOG can be ameliorated by 60 Hz stimulation in some patients. It is not clear whether the development of FOG is due to the disease progression or the chronic stimulation at this 130 Hz frequency. AIMS: To investigate the effect of stimulation frequency on immediate FOG in newly activated STN DBS patient with PD and determine if stimulation frequency alone could affect the FOG. METHODS: Two cases of PD who developed FOG immediately upon activation of the newly placed STN DBS were studied for the effect of stimulation frequency on FOG in both `off' and `on' medication status. RESULTS: Both patients developed severe FOG with the commonly used 130 Hz stimulation. Switching the frequency to 60 Hz immediately alleviated the FOG, without change in contacts, voltages and pulse widths. This frequency effect on FOG was present in both `off' and `on' statuses and remained effective during the 10-month follow-up period. CONCLUSION: These two cases demonstrate that lower frequency stimulation of 60 Hz could improve FOG, while the commonly used 130 Hz stimulation could cause FOG or make it worse. In addition, the beneficial effect of low frequency DBS was additive to dopaminergic medication effect and included other axial symptoms.
Authors: Elie Matar; James M Shine; Moran Gilat; Kaylena A Ehgoetz Martens; Philip B Ward; Michael J Frank; Ahmed A Moustafa; Sharon L Naismith; Simon J G Lewis Journal: Hum Brain Mapp Date: 2019-01-13 Impact factor: 5.038
Authors: Chioma Anidi; Johanna J O'Day; Ross W Anderson; Muhammad Furqan Afzal; Judy Syrkin-Nikolau; Anca Velisar; Helen M Bronte-Stewart Journal: Neurobiol Dis Date: 2018-09-06 Impact factor: 5.996
Authors: Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem Journal: Nat Rev Neurol Date: 2015-01-13 Impact factor: 42.937
Authors: Amy W Amara; Harrison C Walker; Allen Joop; Gary Cutter; Jennifer L DeWolfe; Susan M Harding; David G Standaert Journal: Mov Disord Clin Pract Date: 2016-06-06
Authors: Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis Journal: Brain Date: 2020-01-01 Impact factor: 13.501
Authors: Andrea A Kühn; R Mark Richardson; Wolf-Julian Neumann; Robert S Turner; Benjamin Blankertz; Tom Mitchell Journal: Neurotherapeutics Date: 2019-01 Impact factor: 7.620
Authors: Rajal G Cohen; Krystal A Klein; Mariko Nomura; Michael Fleming; Martina Mancini; Nir Giladi; John G Nutt; Fay B Horak Journal: J Parkinsons Dis Date: 2014 Impact factor: 5.568